Neurocrine Biosciences
NBIX
NBIX
576 hedge funds and large institutions have $12.4B invested in Neurocrine Biosciences in 2025 Q2 according to their latest regulatory filings, with 76 funds opening new positions, 220 increasing their positions, 220 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
4.08% more ownership
Funds ownership: 95.71% → 99.78% (+4.1%)
0% more repeat investments, than reductions
Existing positions increased: 220 | Existing positions reduced: 220
0% less funds holding
Funds holding: 577 → 576 (-1)
Holders
576
Holding in Top 10
15
Calls
$37.7M
Puts
$27M
Top Buyers
| 1 | +$200M | |
| 2 | +$194M | |
| 3 | +$146M | |
| 4 |
RI
RTW Investments
New York
|
+$133M |
| 5 |
Los Angeles Capital Management
Los Angeles,
California
|
+$93.1M |
Top Sellers
| 1 | -$217M | |
| 2 | -$62.4M | |
| 3 | -$49.5M | |
| 4 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
-$44.2M |
| 5 |
VRS
Virginia Retirement Systems
Richmond,
Virginia
|
-$42M |